The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended revoking the European Union marketing authorization ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European UnionJune 26, 2026 9:00 AM